• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    InDex Pharmaceuticals discontinues cobitolimod phase III program

    PR NEWSWIRE

    InDex Pharmaceuticals announces that all patients needed for the cobitolimod dose selection milestone have completed Induction Study 1 of the phase III program CONCLUDE

    PR NEWSWIRE

    Positive results from PK study with cobitolimod` selected as one of the best abstracts for presentation

    PR NEWSWIRE

    InDex Pharma has been granted a new patent in Europe for cobitolimod

    PR NEWSWIRE

    InDex announces positive results from PK study with cobitolimod

    PR NEWSWIRE

    InDex updates the timeline of the phase III study CONCLUDE with cobitolimod

    PR NEWSWIRE

    InDex Pharma successfully interacts with PMDA for cobitolimod in Japan

    PRNEWSWIRE

    InDex Pharmaceuticals gets new patent for cobitolimod granted in Europe

    PRNEWSWIRE

    InDex Pharmaceuticals prepares for commercialisation of cobitolimod

    PRNEWSWIRE

    InDex Beings Enrollment in phase III study of cobitolimod in ulcerative colitis

    PRNEWSWIRE

    InDex Pharmaceuticals strengthens the clinical development organization

    PRNEWSWIRE

    InDex Pharma results of phase IIb study with cobitolimod Published in Lancet

    PRNEWSWIRE

    Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.